Recce Ltd has released a press release.
Appendix 4C and commentary
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Appointment of Independent Chair and Additional Director
- USA Patent Granted for Recces Antibiotics
- Recce Successfully Raises $1.8 million via Placement
- Change of Registry Address: Automic P/L - Sydney Office
- Key Australian Patent for Recces Broad-Spectrum Antibiotics
Later from Recce Pharmaceuticals
- Opening R&D Address at World Antibiotic Resistance Congress
- Key Family 2 Patent Granted in Europe for RECCE Antibiotics
- Response to ASX Appendix 4C Query
- FDA Positive Response for Recce Scaled Manufacture & Quality
- Appendix 4E - Preliminary Final Report
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals